Screening for opioid use disorder and co-occurring depression and post-traumatic stress disorder in primary care in New Mexico

Table 2 Prevalence of probable OUD, mental health disorders, and language in universal screening participants versus EHR

	Universal Screening Survey (N = 1478)^a		Clinic EHR Estimates (N = 740)^b		Prevalence Ratio (95% CI)^e
	n (%)	95% CI	n (%)	95% CI	Prevalence Ratio (95% CI)^e
Total participants consented	1145 (77.5%)^c	75.3%, 79.6%	–	–	–
Total participants with probable opioid use disorder	51 (4.5%)^d	3.3%, 5.6%	25 (3.4%)	2.1%, 4.7%	1.32 (0.8, 2.11)
Total participants with probable depression	200 (17.5%)^d	15.3%, 19.7%	94 (12.7%)	10.3%, 15.1%	1.38 (1.10, 1.73)
Total participants with probable post-traumatic stress disorder	218 (19.0%)^d	16.8%, 21.3%	27 (3.6%)	2.3%, 5.0%	5.22 (3.54, 7.70)
Total participants with probable opioid use disorder + co-occurring mental health disorders (depression and/or post-traumatic stress disorder)	27 (2.4%)^d	1.5%, 3.2%	6 (0.8%)	0.2%, 1.5%	2.91 (1.21, 7.01)
Total number monolingual Spanish/took survey in Spanish	122 (10.7%)^d	8.9%, 12.4%	137 (18.5%)	15.7%, 21.3%	0.58 (0.46, 0.72)

EHR electronic health record
^aFor the Universal screening study, this may be an undercount as they were all patients the research staff correctly approached for potential participation. Correctly means the person was age 18 + and was at the clinic for a primary care visit. Some patients may have been missed
^bData collected from the EHR was collected over a 1-year period from October 1, 2018 to September 30, 2019. Counts have been divided by 26 to estimate an average 2-week period for comparison to the pilot data
^cDenominator is patients correctly approached, N = 1478
^dDenominator is patients consented, N = 1145
^eBolded values indicate prevalence ratio is statistically significant, assuming a type I error level of 0.05

ISSN: 1940-0640